bay-73-6691 and Learning-Disabilities

bay-73-6691 has been researched along with Learning-Disabilities* in 1 studies

Other Studies

1 other study(ies) available for bay-73-6691 and Learning-Disabilities

ArticleYear
The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:10

    Several phosphodiesterase inhibitors (PDEis) improve cognition, suggesting that an increase in brain cAMP and cGMP facilitates learning and memory. Since extinction of drug-seeking behavior requires associative learning, consolidation and formation of new memory, the present study investigated the efficacy of three different PDEis in the extinction of cocaine-induced conditioned place preference (CPP) in B6129S mice. Mice were conditioned by escalating doses of cocaine which was resistant to extinction by free exploration. Immediately following each extinction session mice received (a) saline/vehicle, (b) rolipram (PDE4 inhibitor), (c) BAY-73-6691 (PDE9 inhibitor) or (d) papaverine (PDE10A inhibitor). Mice that received saline/vehicle during extinction training showed no reduction in CPP for >10 days. BAY-73-6691 (a) dose-dependently increased cGMP in hippocampus and amygdala, (b) significantly facilitated extinction and (c) diminished the reinstatement of cocaine CPP. Rolipram, which selectively increased brain cAMP levels, and papaverine which caused increases in both cAMP and cGMP levels, had no significant effect on the extinction of cocaine CPP. The results suggest that increase in hippocampal and amygdalar cGMP levels via blockade of PDE9 has a prominent role in the consolidation of extinction learning.

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amygdala; Animals; Association Learning; Behavior, Animal; Cocaine; Cyclic GMP; Dose-Response Relationship, Drug; Extinction, Psychological; Hippocampus; Learning Disabilities; Male; Memory, Long-Term; Mice; Mice, 129 Strain; Molecular Targeted Therapy; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Phosphodiesterase Inhibitors; Pyrazoles; Pyrimidines; Spatial Behavior

2012